Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531 | Journal of Clinical Oncology
The Expression Pattern of the Pre-B Cell Receptor Components Correlates with Cellular Stage and Clinical Outcome in Acute Lymphoblastic Leukemia | PLOS ONE
Cureus | Absolute Lymphocyte Count at Day 28 Independently Predicts Event- Free and Overall Survival in Adults with Newly Diagnosed Acute Lymphocytic Leukemia
Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan | Scientific Reports
View Image
Acute Lymphoblastic Leukemia | NEJM
SciELO - Brasil - Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival
Cancers | Free Full-Text | Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study
Overall survival and event-free survival according to primary... | Download Scientific Diagram
Kaplan–Meier Estimates of Event-free and Overall Survival among... | Download Scientific Diagram
A) Overall survival, (B) relapse-free survival, and (C) event-free... | Download Scientific Diagram
Kaplan-Meier survival curves of event-free survival (EFS) and overall... | Download Scientific Diagram
ASH 2022: FLAG-Ida Combined with Gemtuzumab Ozogamicin (GO) Improves Event Free Survival in Younger Patients with Newly Diagnosed Acute Myeloid Leukaemia (AML) and Shows an Overall Survival Benefit in NPM1 and FLT3
Kaplan-Meier overall survival and event free survival curves of acute... | Download Scientific Diagram
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer | NEJM
Kaplan-Meier overall survival (OS) and event-free survival (EFS)... | Download Scientific Diagram
First Randomized Trial to Show Benefit of Tyrosine Kinase Inhibitor in Newly Diagnosed Acute Myeloid Leukemia - The ASCO Post
Reduced–dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study - ScienceDirect
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols | Haematologica
Treatment of Acute Lymphoblastic Leukemia -- 30 Years' Experience at St. Jude Children's Research Hospital | NEJM
A novel event-free survival endpoint in locally advanced pancreatic cancer - Pascal Hammel, Ewa Carrier, Mairead Carney, Mark Eisner, Thomas Fleming, 2021
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study | Leukemia
The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study - Gupta - 2019 - Cancer Medicine - Wiley Online Library
Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study
